Australia markets open in 7 hours 5 minutes

Evofem Biosciences, Inc. (EVFM)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0154+0.0005 (+3.02%)
As of 12:28PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 684.50k
Enterprise value 44.06M
Trailing P/E 0.30
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.80
Price/book (mrq)N/A
Enterprise value/revenue 2.42
Enterprise value/EBITDA -2.74

Trading information

Stock price history

Beta (5Y monthly) -1.16
52-week change 3-99.43%
S&P500 52-week change 322.64%
52-week high 33.7500
52-week low 30.0120
50-day moving average 30.0202
200-day moving average 30.1293

Share statistics

Avg vol (3-month) 3844.07k
Avg vol (10-day) 3650.76k
Shares outstanding 545.94M
Implied shares outstanding 645.94M
Float 845.94M
% held by insiders 10.00%
% held by institutions 10.22%
Shares short (29 July 2022) 469.46k
Short ratio (29 July 2022) 40.19
Short % of float (29 July 2022) 411.01%
Short % of shares outstanding (29 July 2022) 410.98%
Shares short (prior month 30 June 2022) 4142.57k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Jan 2018
Ex-dividend date 4N/A
Last split factor 21:125
Last split date 318 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 290.81%
Operating margin (ttm)-69.85%

Management effectiveness

Return on assets (ttm)-62.46%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)18.22M
Revenue per share (ttm)3.77
Quarterly revenue growth (yoy)2,573.50%
Gross profit (ttm)N/A
EBITDA -17.37M
Net income avi to common (ttm)49.99M
Diluted EPS (ttm)0.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)43.37M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.13
Book value per share (mrq)-3.32

Cash flow statement

Operating cash flow (ttm)-8.97M
Levered free cash flow (ttm)-7.15M